Skip to content

Post-market Study of the Biodesign Hernia Graft

Ventral Hernia

The purpose of this study is to collect data on the performance of the Biodesign® Hernia Graft when used to reinforce soft tissues during ventral hernia repair.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

1. Primary or recurrent ventral hernia in need of surgical repair utilizing a Biodesign Hernia Graft

Exclusion Criteria:

1. Known sensitivity to porcine material

For the study, the following patients will also be excluded:
2. Age \< 18 years
3. Unable or unwilling to provide informed consent
4. Life expectancy of less than one year from the date of the index procedure
5. Patients will be excluded from the study if they never receive a Biodesign Hernia Graft during their index procedure.

Lieu de l'étude

St. Paul's Hospital
St. Paul's Hospital
Vancouver, British Columbia
Canada

Contactez l'équipe d'étude

Primary Contact

Jerry Liu

[email protected]
604-682-2344
Queen Elizabeth II Hospital
Queen Elizabeth II Hospital
Halifax, Nova Scotia
Canada

Contactez l'équipe d'étude

Primary Contact

Lisa Julien, RN

[email protected]
902-473-3877
Étude parrainée par
Cook Biotech Incorporated
Participants recherchés
Plus d'informations
ID de l'étude: NCT04294446